drugset / Trial / NCT07034898

Dexmedetomidine vs Labetalol for Airway Stress in Hypertensive Craniotomy Patients

NCT07034898

Phase 4 Enrolling by invitation 60 enrolled Ain Shams University
RandomizedParallel-groupDouble-blindTreatment

Summary

This randomized trial compares dexmedetomidine and labetalol in controlling airway and hemodynamic stress during extubation in hypertensive patients undergoing craniotomy. Outcomes include extubation quality, vital signs, sedation, and adverse effects.

Timeline

Start
2025-04-01
Primary completion
2025-08-31
Completion
2025-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.5 ug/kg Intravenous
Subject Labetalol Small molecule 0.5 mg/kg Intravenous